Prostate Cancer Drugs Market Report

Global and China Prostate Cancer Drugs Industry Market Research Report (2017-2028)

  • POSTDATE：Dec 20, 2022
  • PAGES：211
  • REPORT CODE：GMM1478399
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Prostate Cancer Drugs industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Sanofi

    • Northwest Biotherapeutics

    • Ferring Pharmaceutical

    • Spectrum Pharmaceuticals

    • Boehringer Ingelheim

    • Astellas Pharma

    • Johnson & Johnson

    • Takeda Pharmaceuticals

    • Bayer HealthCare

    • Endo Pharmaceuticals

    • Tokai Pharmaceuticals

    • AbbVie

    • Novartis

    • Amgen

    • Merck Group

    • BMS

    • Teva Pharmaceutical

    • GlaxoSmithKline

    • Foresee Pharmaceuticals

    • Janssen Pharmaceuticals

    • Astra Zeneca

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Hormonal Therapy

    • Chemotherapy

    • Immunotherapy

    • Targeted Therapy

    Application:

    • Clinics

    • Hospitals

    • Other

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Prostate Cancer Drugs Industry Overview

      • 1.1.1 Prostate Cancer Drugs Market Scope and Market Segments

      • 1.1.2 Prostate Cancer Drugs Industry Characteristics

      • 1.1.3 Global and China Prostate Cancer Drugs Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Prostate Cancer Drugs Production Value and Growth Rate (2017-2028)

    • 1.2 Global Prostate Cancer Drugs Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Hormonal Therapy

      • 1.2.2 Chemotherapy

      • 1.2.3 Immunotherapy

      • 1.2.4 Targeted Therapy

    • 1.3 Global Prostate Cancer Drugs Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Clinics

      • 1.3.2 Hospitals

      • 1.3.3 Other

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Prostate Cancer Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Prostate Cancer Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Prostate Cancer Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Prostate Cancer Drugs Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Prostate Cancer Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Prostate Cancer Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Prostate Cancer Drugs Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Prostate Cancer Drugs Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Prostate Cancer Drugs Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Prostate Cancer Drugs Industry Porter's Five Forces Model Analysis

      • 2.2.3 Prostate Cancer Drugs Industry PEST Analysis

    • 2.3 Prostate Cancer Drugs Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Prostate Cancer Drugs Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Prostate Cancer Drugs Industry

    Chapter 3 Global and China Prostate Cancer Drugs Market, by Manufacturer

    • 3.1 Global and China Prostate Cancer Drugs Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Prostate Cancer Drugs Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Prostate Cancer Drugs Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Prostate Cancer Drugs Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Prostate Cancer Drugs Market Top 3 Players

    Chapter 4 Global and China Prostate Cancer Drugs Market, by Type (2017-2028)

    • 4.1 Prostate Cancer Drugs Market Trend, by Type

    • 4.2 Global Prostate Cancer Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Prostate Cancer Drugs Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Prostate Cancer Drugs Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Prostate Cancer Drugs Price Trend, by Type (2017-2028)

    • 4.3 China Prostate Cancer Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Prostate Cancer Drugs Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Prostate Cancer Drugs Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Prostate Cancer Drugs Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Prostate Cancer Drugs Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Prostate Cancer Drugs Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Prostate Cancer Drugs Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Prostate Cancer Drugs Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Prostate Cancer Drugs Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Prostate Cancer Drugs Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Prostate Cancer Drugs Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Prostate Cancer Drugs Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Prostate Cancer Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Prostate Cancer Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Prostate Cancer Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Prostate Cancer Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Prostate Cancer Drugs Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Prostate Cancer Drugs Market Analysis

    • 7.1 North America Prostate Cancer Drugs Market, by Type

    • 7.2 North America Prostate Cancer Drugs Market, by Application

    • 7.3 North America Prostate Cancer Drugs Market Analysis and Forecast, by Country

      • 7.3.1 United States Prostate Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Prostate Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Prostate Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Prostate Cancer Drugs Market Analysis

    • 8.1 Europe Prostate Cancer Drugs Market, by Type

    • 8.2 Europe Prostate Cancer Drugs Market, by Application

    • 8.3 Europe Prostate Cancer Drugs Market Analysis and Forecast, by Country

      • 8.3.1 Germany Prostate Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Prostate Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Prostate Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Prostate Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Prostate Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Prostate Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Prostate Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Prostate Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Prostate Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Prostate Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Prostate Cancer Drugs Market Analysis

    • 9.1 APAC Prostate Cancer Drugs Market, by Type

    • 9.2 APAC Prostate Cancer Drugs Market, by Application

    • 9.3 APAC Prostate Cancer Drugs Market Analysis and Forecast, by Country

      • 9.3.1 China Prostate Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Prostate Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Prostate Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Prostate Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Prostate Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Prostate Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Prostate Cancer Drugs Market Analysis

    • 10.1 Latin America, Middle East and Africa Prostate Cancer Drugs Market, by Type

    • 10.2 Latin America, Middle East and Africa Prostate Cancer Drugs Market, by Application

    • 10.3 Latin America, Middle East and Africa Prostate Cancer Drugs Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Prostate Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Prostate Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Prostate Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Prostate Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Prostate Cancer Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Prostate Cancer Drugs Company Profiles

      • 11.1 Sanofi

        • 11.1.1 Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Sanofi Prostate Cancer Drugs Product Profiles, Application and Specification

        • 11.1.3 Sanofi Prostate Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Northwest Biotherapeutics

        • 11.2.1 Northwest Biotherapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Northwest Biotherapeutics Prostate Cancer Drugs Product Profiles, Application and Specification

        • 11.2.3 Northwest Biotherapeutics Prostate Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Ferring Pharmaceutical

        • 11.3.1 Ferring Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Ferring Pharmaceutical Prostate Cancer Drugs Product Profiles, Application and Specification

        • 11.3.3 Ferring Pharmaceutical Prostate Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Spectrum Pharmaceuticals

        • 11.4.1 Spectrum Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Spectrum Pharmaceuticals Prostate Cancer Drugs Product Profiles, Application and Specification

        • 11.4.3 Spectrum Pharmaceuticals Prostate Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Boehringer Ingelheim

        • 11.5.1 Boehringer Ingelheim Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Boehringer Ingelheim Prostate Cancer Drugs Product Profiles, Application and Specification

        • 11.5.3 Boehringer Ingelheim Prostate Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Astellas Pharma

        • 11.6.1 Astellas Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Astellas Pharma Prostate Cancer Drugs Product Profiles, Application and Specification

        • 11.6.3 Astellas Pharma Prostate Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Johnson & Johnson

        • 11.7.1 Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Johnson & Johnson Prostate Cancer Drugs Product Profiles, Application and Specification

        • 11.7.3 Johnson & Johnson Prostate Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Takeda Pharmaceuticals

        • 11.8.1 Takeda Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Takeda Pharmaceuticals Prostate Cancer Drugs Product Profiles, Application and Specification

        • 11.8.3 Takeda Pharmaceuticals Prostate Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Bayer HealthCare

        • 11.9.1 Bayer HealthCare Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Bayer HealthCare Prostate Cancer Drugs Product Profiles, Application and Specification

        • 11.9.3 Bayer HealthCare Prostate Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Endo Pharmaceuticals

        • 11.10.1 Endo Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Endo Pharmaceuticals Prostate Cancer Drugs Product Profiles, Application and Specification

        • 11.10.3 Endo Pharmaceuticals Prostate Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Tokai Pharmaceuticals

        • 11.11.1 Tokai Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Tokai Pharmaceuticals Prostate Cancer Drugs Product Profiles, Application and Specification

        • 11.11.3 Tokai Pharmaceuticals Prostate Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 AbbVie

        • 11.12.1 AbbVie Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 AbbVie Prostate Cancer Drugs Product Profiles, Application and Specification

        • 11.12.3 AbbVie Prostate Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.13 Novartis

        • 11.13.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.13.2 Novartis Prostate Cancer Drugs Product Profiles, Application and Specification

        • 11.13.3 Novartis Prostate Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.14 Amgen

        • 11.14.1 Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.14.2 Amgen Prostate Cancer Drugs Product Profiles, Application and Specification

        • 11.14.3 Amgen Prostate Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.15 Merck Group

        • 11.15.1 Merck Group Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.15.2 Merck Group Prostate Cancer Drugs Product Profiles, Application and Specification

        • 11.15.3 Merck Group Prostate Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.16 BMS

        • 11.16.1 BMS Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.16.2 BMS Prostate Cancer Drugs Product Profiles, Application and Specification

        • 11.16.3 BMS Prostate Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.17 Teva Pharmaceutical

        • 11.17.1 Teva Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.17.2 Teva Pharmaceutical Prostate Cancer Drugs Product Profiles, Application and Specification

        • 11.17.3 Teva Pharmaceutical Prostate Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.18 GlaxoSmithKline

        • 11.18.1 GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.18.2 GlaxoSmithKline Prostate Cancer Drugs Product Profiles, Application and Specification

        • 11.18.3 GlaxoSmithKline Prostate Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.19 Foresee Pharmaceuticals

        • 11.19.1 Foresee Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.19.2 Foresee Pharmaceuticals Prostate Cancer Drugs Product Profiles, Application and Specification

        • 11.19.3 Foresee Pharmaceuticals Prostate Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.20 Janssen Pharmaceuticals

        • 11.20.1 Janssen Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.20.2 Janssen Pharmaceuticals Prostate Cancer Drugs Product Profiles, Application and Specification

        • 11.20.3 Janssen Pharmaceuticals Prostate Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.21 Astra Zeneca

        • 11.21.1 Astra Zeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.21.2 Astra Zeneca Prostate Cancer Drugs Product Profiles, Application and Specification

        • 11.21.3 Astra Zeneca Prostate Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Prostate Cancer Drugs Industry Investment Prospect and Risk Assessment

    • 12.1 Prostate Cancer Drugs Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Prostate Cancer Drugs Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Prostate Cancer Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure China Prostate Cancer Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Global Prostate Cancer Drugs Production Value and Growth Rate (2017-2028)

    • Figure China Prostate Cancer Drugs Production Value and Growth Rate (2017-2028)

    • Figure Global Prostate Cancer Drugs Market Size and Growth Rate of Hormonal Therapy (2017-2028)

    • Figure Global Prostate Cancer Drugs Market Size and Growth Rate of Chemotherapy (2017-2028)

    • Figure Global Prostate Cancer Drugs Market Size and Growth Rate of Immunotherapy (2017-2028)

    • Figure Global Prostate Cancer Drugs Market Size and Growth Rate of Targeted Therapy (2017-2028)

    • Figure Global Prostate Cancer Drugs Market Size and Growth Rate of Clinics (2017-2028)

    • Figure Global Prostate Cancer Drugs Market Size and Growth Rate of Hospitals (2017-2028)

    • Figure Global Prostate Cancer Drugs Market Size and Growth Rate of Other (2017-2028)

    • Figure North America Prostate Cancer Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Prostate Cancer Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Prostate Cancer Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Prostate Cancer Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Prostate Cancer Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Prostate Cancer Drugs Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Prostate Cancer Drugs Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Prostate Cancer Drugs Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Prostate Cancer Drugs Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Prostate Cancer Drugs Market Share, by Manufacturer in 2021

    • Figure Global and China Prostate Cancer Drugs Market Share, by Manufacturer in 2022

    • Table Global Prostate Cancer Drugs Sales Volume, by Type (2017-2028)

    • Table Global Prostate Cancer Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Global Prostate Cancer Drugs Sales Volume Share, by Type (2017-2028)

    • Table Global Prostate Cancer Drugs Sales Value, by Type (2017-2028)

    • Table Global Prostate Cancer Drugs Sales Value Share, by Type (2017-2028)

    • Figure Global Prostate Cancer Drugs Price Trend, by Type (2017-2028)

    • Table China Prostate Cancer Drugs Sales Volume, by Type (2017-2028)

    • Table China Prostate Cancer Drugs Sales Volume Share, by Type (2017-2028)

    • Figure China Prostate Cancer Drugs Sales Volume Share, by Type (2017-2028)

    • Table China Prostate Cancer Drugs Sales Value, by Type (2017-2028)

    • Table China Prostate Cancer Drugs Sales Value Share, by Type (2017-2028)

    • Figure China Prostate Cancer Drugs Price Trend, by Type (2017-2028)

    • Table Global Prostate Cancer Drugs Sales Volume, by Application (2017-2028)

    • Table Global Prostate Cancer Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Global Prostate Cancer Drugs Sales Volume Share, by Application (2017-2028)

    • Table Global Prostate Cancer Drugs Sales Value, by Application (2017-2028)

    • Table Global Prostate Cancer Drugs Sales Value Share, by Application (2017-2028)

    • Figure Global Prostate Cancer Drugs Sales Value Share, by Application (2017-2028)

    • Table China Prostate Cancer Drugs Sales Volume, by Application (2017-2028)

    • Table China Prostate Cancer Drugs Sales Volume Share, by Application (2017-2028)

    • Figure China Prostate Cancer Drugs Sales Volume Share, by Application (2017-2028)

    • Table China Prostate Cancer Drugs Sales Value, by Application (2017-2028)

    • Table China Prostate Cancer Drugs Sales Value Share, by Application (2017-2028)

    • Figure China Prostate Cancer Drugs Sales Value Share, by Application (2017-2028)

    • Figure China Prostate Cancer Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure North America Prostate Cancer Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Prostate Cancer Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Prostate Cancer Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Prostate Cancer Drugs Production, Import, Consumption and Export (2017-2022)

    • Table North America Prostate Cancer Drugs Sales Volume, by Type (2017-2028)

    • Table North America Prostate Cancer Drugs Sales Volume Share, by Type (2017-2028)

    • Figure North America Prostate Cancer Drugs Sales Volume Share, by Type (2017-2028)

    • Table North America Prostate Cancer Drugs Sales Volume, by Application (2017-2028)

    • Table North America Prostate Cancer Drugs Sales Volume Share, by Application (2017-2028)

    • Figure North America Prostate Cancer Drugs Sales Volume Share, by Application (2017-2028)

    • Figure United States Prostate Cancer Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure United States Prostate Cancer Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Canada Prostate Cancer Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Prostate Cancer Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Prostate Cancer Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Prostate Cancer Drugs Sales Value and Growth Rate (2017-2028)

    • Table Europe Prostate Cancer Drugs Sales Volume, by Type (2017-2028)

    • Table Europe Prostate Cancer Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Europe Prostate Cancer Drugs Sales Volume Share, by Type (2017-2028)

    • Table Europe Prostate Cancer Drugs Sales Volume, by Application (2017-2028)

    • Table Europe Prostate Cancer Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Europe Prostate Cancer Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Germany Prostate Cancer Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Prostate Cancer Drugs Sales Value and Growth Rate (2017-2028)

    • Figure UK Prostate Cancer Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure UK Prostate Cancer Drugs Sales Value and Growth Rate (2017-2028)

    • Figure France Prostate Cancer Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure France Prostate Cancer Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Italy Prostate Cancer Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Prostate Cancer Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Prostate Cancer Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Prostate Cancer Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Spain Prostate Cancer Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Prostate Cancer Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Prostate Cancer Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Prostate Cancer Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Poland Prostate Cancer Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Prostate Cancer Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Russia Prostate Cancer Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Prostate Cancer Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Prostate Cancer Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Prostate Cancer Drugs Sales Value and Growth Rate (2017-2028)

    • Table APAC Prostate Cancer Drugs Sales Volume, by Type (2017-2028)

    • Table APAC Prostate Cancer Drugs Sales Volume Share, by Type (2017-2028)

    • Figure APAC Prostate Cancer Drugs Sales Volume Share, by Type (2017-2028)

    • Table APAC Prostate Cancer Drugs Sales Volume, by Application (2017-2028)

    • Table APAC Prostate Cancer Drugs Sales Volume Share, by Application (2017-2028)

    • Figure APAC Prostate Cancer Drugs Sales Volume Share, by Application (2017-2028)

    • Figure China Prostate Cancer Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure China Prostate Cancer Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Japan Prostate Cancer Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Prostate Cancer Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Prostate Cancer Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Prostate Cancer Drugs Sales Value and Growth Rate (2017-2028)

    • Figure India Prostate Cancer Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure India Prostate Cancer Drugs Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Prostate Cancer Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Prostate Cancer Drugs Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Prostate Cancer Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Prostate Cancer Drugs Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Prostate Cancer Drugs Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Prostate Cancer Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Prostate Cancer Drugs Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Prostate Cancer Drugs Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Prostate Cancer Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Prostate Cancer Drugs Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Prostate Cancer Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Prostate Cancer Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Prostate Cancer Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Prostate Cancer Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Prostate Cancer Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Prostate Cancer Drugs Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Prostate Cancer Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Prostate Cancer Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Prostate Cancer Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Prostate Cancer Drugs Sales Value and Growth Rate (2017-2028)

    • Table Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sanofi Product Profiles, Application and Specification

    • Table Sanofi Prostate Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Northwest Biotherapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Northwest Biotherapeutics Product Profiles, Application and Specification

    • Table Northwest Biotherapeutics Prostate Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Ferring Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Ferring Pharmaceutical Product Profiles, Application and Specification

    • Table Ferring Pharmaceutical Prostate Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Spectrum Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Spectrum Pharmaceuticals Product Profiles, Application and Specification

    • Table Spectrum Pharmaceuticals Prostate Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Boehringer Ingelheim Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Boehringer Ingelheim Product Profiles, Application and Specification

    • Table Boehringer Ingelheim Prostate Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Astellas Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Astellas Pharma Product Profiles, Application and Specification

    • Table Astellas Pharma Prostate Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Johnson & Johnson Product Profiles, Application and Specification

    • Table Johnson & Johnson Prostate Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Takeda Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Takeda Pharmaceuticals Product Profiles, Application and Specification

    • Table Takeda Pharmaceuticals Prostate Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bayer HealthCare Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bayer HealthCare Product Profiles, Application and Specification

    • Table Bayer HealthCare Prostate Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Endo Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Endo Pharmaceuticals Product Profiles, Application and Specification

    • Table Endo Pharmaceuticals Prostate Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Tokai Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Tokai Pharmaceuticals Product Profiles, Application and Specification

    • Table Tokai Pharmaceuticals Prostate Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table AbbVie Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AbbVie Product Profiles, Application and Specification

    • Table AbbVie Prostate Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis Product Profiles, Application and Specification

    • Table Novartis Prostate Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Amgen Product Profiles, Application and Specification

    • Table Amgen Prostate Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Merck Group Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Merck Group Product Profiles, Application and Specification

    • Table Merck Group Prostate Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table BMS Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table BMS Product Profiles, Application and Specification

    • Table BMS Prostate Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Teva Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Teva Pharmaceutical Product Profiles, Application and Specification

    • Table Teva Pharmaceutical Prostate Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GlaxoSmithKline Product Profiles, Application and Specification

    • Table GlaxoSmithKline Prostate Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Foresee Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Foresee Pharmaceuticals Product Profiles, Application and Specification

    • Table Foresee Pharmaceuticals Prostate Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Janssen Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Janssen Pharmaceuticals Product Profiles, Application and Specification

    • Table Janssen Pharmaceuticals Prostate Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Astra Zeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Astra Zeneca Product Profiles, Application and Specification

    • Table Astra Zeneca Prostate Cancer Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US